Dapawick Lina Met 500mg Tablet

LINALIGLIP DAPAMET 500 mg Tablet is a fixed-dose combination of three antidiabetic agents:

• Dapagliflozin (10 mg) – a Sodium-Glucose Cotransporter 2 (SGLT2) inhibitor

• Linagliptin (5 mg) – a Dipeptidyl Peptidase-4 (DPP-4) inhibitor

• Metformin (500 mg) – a Biguanide

This triple combination is used to improve glycemic control in adults with type 2 diabetes mellitus when diet, exercise, and dual therapy are insufficient.

USES

• Management of Type 2 Diabetes Mellitus (T2DM) in adults

• As an adjunct to diet and exercise to improve blood glucose control

• May reduce the risk of cardiovascular events in diabetic patients with established cardiovascular disease (due to dapagliflozin)

BENEFITS

• Improved blood sugar control through complementary mechanisms of action:

  • Dapagliflozin increases urinary glucose excretion

  • Linagliptin enhances incretin hormones to stimulate insulin secretion

  • Metformin reduces hepatic glucose production

• Weight management benefit (due to dapagliflozin)

• Low risk of hypoglycemia compared to some other therapies

• Cardiovascular and renal protection (dapagliflozin has demonstrated benefits in some patients)

• Convenient single-tablet regimen improves adherence

SIDE EFFECTS

Common Side Effects:

• Urinary tract infections (UTIs)

• Genital fungal infections

• Nausea or vomiting

• Diarrhea or stomach upset (mainly due to Metformin)

• Headache

Less Common / Serious Side Effects:

• Hypoglycemia (especially when used with other antidiabetics like insulin or sulfonylureas)

• Dehydration or increased urination

• Ketoacidosis (rare but serious – monitor for symptoms like nausea, vomiting, abdominal pain)

• Pancreatitis (rare)

• Lactic acidosis (a rare but serious side effect of Metformin)

• Allergic reactions or skin rash